Editorials |
From Pulmonary, Allergy and Critical Care Medicine (M.T.G.); the Department of Pharmacology and Chemical Biology (S.S.); and the Hemostasis and Vascular Biology Research Institute (M.T.G., S.S.), University of Pittsburgh, Pa.
Correspondence to Dr Mark T. Gladwin, Pulmonary, Allergy and Critical Care Medicine, Hemostasis and Vascular Biology Research Institute, University of Pittsburgh, NW 628 Montefiore Hospital, 3459 Fifth Ave, Pittsburgh, PA 15213. E-mail gladwinmt@upmc.edu
See related article, pages 1178–1183
Key Words: microcirculation nitric oxide nitric oxide synthase reperfusion injury hemoglobin
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
| Introduction |
|---|
Interestingly, the binding of NO to cytochrome c oxidase is unique for 2 major reasons (1) Unlike the binding of NO to deoxyhemoglobin or myoglobin, which has a very low dissociation rate, the binding of NO to cytochrome c oxidase is reversible; NO is released as the enzyme cycles. This means that NO-dependent inhibition of respiration is reversible.1,3 (2) Perhaps more importantly, the binding of NO to cytochrome c oxidase is regulated by oxygen, such that NO is a more potent inhibitor of respiration as oxygen tension decreases.1,3,4
The binding of NO to cytochrome c oxidase and
Related Article:
Circ. Res. 2009 104: 1178-1183.
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |